DEA comment period ends. GOP lawmakers express doubt about rescheduling marijuana but are out of sync with a majority of Americans. Promising research on cancer treatment and among drug abusers. Watch our Journal Club and read two studies on the reduction of craving among users. The troubles with testing labs continue.
DEA Comment period ends with a majority in favor of rescheduling and rules changes https://www.theguardian.com/society/article/2024/jul/27/dea-cannabis-classification
GOP lawmakers express doubt about marijuana rescheduling https://mjbizdaily.com/dea-still-has-doubts-about-marijuana-rescheduling-gop-lawmakers-claim/
Pew Research Center says more than half of Americans favor legalization https://www.pewresearch.org/politics/2024/03/26/most-americans-favor-legalizing-marijuana-for-medical-recreational-use/
Promising in results in cancer treatment study https://www.marijuanamoment.net/lesser-known-marijuana-components-can-be-promising-anticancer-agents-study-on-multiple-myeloma-finds/
Another promising study about benefits of marijuana among opioid users https://www.sciencedirect.com/science/article/pii/S2772724624000416
An earlier study on CBD to reduce craving among opioid users https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462449
Watch our Journal Club reviewing on the reduction of craving among heroin users in withdrawal https://app.searchie.io/watch/mpDokRalD4 Here’s the study https://psychiatryonline.org/doi/10.1176/appi.ajp.2019.18101191
Troubles with a California testing lab https://mjbizdaily.com/california-regulators-revoke-marijuana-testing-lab-license-for-faking-results/
